MG
Mara Goldstein Mizuho Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Kura Oncology
KURA
$713M
| $8.22 | $30 |
265%
upside
| Outperform | 3 months ago |
|
2
Iovance Biotherapeutics
IOVA
$905M
| $2.50 | $10 |
300%
upside
| Outperform | 3 months ago |
|
3
Verastem
VSTM
$663M
| $10.78 | $8 |
26%
downside
| Outperform | 4 months ago |
|
4
Arcus Biosciences
RCUS
$1.3B
| $12.22 | $42 |
244%
upside
| Buy | 1 year ago |
|
5
Xencor
XNCR
$610M
| $8.55 | $50 |
485%
upside
| Buy | 1 year ago |
|
6
Syndax Pharmaceuticals
SNDX
$1.47B
| $17.05 | $45 |
164%
upside
| Buy | 1 year ago |
|
7
Incyte
INCY
$16.9B
| $86.64 | $77 |
11%
downside
| Neutral | 1 year ago |
|
8
Erasca
ERAS
$454M
| $1.60 | $7 |
338%
upside
| Buy | 1 year ago |
|
9
Nektar Therapeutics
NKTR
$763M
| $40.10 | $90 |
124%
upside
| Neutral | 2 years ago |
|
10
Corvus Pharmaceuticals
CRVS
$459M
| $6.16 | $3.50 |
43%
downside
| Neutral | 2 years ago |
|
11
Merck
MRK
$212B
| $84.71 | $130 |
53%
upside
| Buy | 2 years ago |
|
12
CytomX Therapeutics
CTMX
$374M
| $2.27 | $2 |
12%
downside
| Neutral | 2 years ago |
|
|
AUTL
13
Autolus Therapeutics
AUTL
$386M
| $1.45 | $12 |
728%
upside
| Buy | 2 years ago |
|